These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10197048)

  • 1. Central control of feeding behavior by neuropeptide Y.
    Zimanyi IA; Fathi Z; Poindexter GS
    Curr Pharm Des; 1998 Aug; 4(4):349-66. PubMed ID: 10197048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
    Lecklin A; Lundell I; Paananen L; Wikberg JE; Männistö PT; Larhammar D
    Br J Pharmacol; 2002 Apr; 135(8):2029-37. PubMed ID: 11959807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.
    Hwa JJ; Witten MB; Williams P; Ghibaudi L; Gao J; Salisbury BG; Mullins D; Hamud F; Strader CD; Parker EM
    Am J Physiol; 1999 Nov; 277(5):R1428-34. PubMed ID: 10564216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y stimulates food intake in the Zebrafish, Danio rerio.
    Yokobori E; Azuma M; Nishiguchi R; Kang KS; Kamijo M; Uchiyama M; Matsuda K
    J Neuroendocrinol; 2012 May; 24(5):766-73. PubMed ID: 22250860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists.
    Balasubramaniam A
    Curr Pharm Des; 2003; 9(15):1165-75. PubMed ID: 12769744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y and its receptors as potential therapeutic drug targets.
    Silva AP; Cavadas C; Grouzmann E
    Clin Chim Acta; 2002 Dec; 326(1-2):3-25. PubMed ID: 12417094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
    Parker E; Van Heek M; Stamford A
    Eur J Pharmacol; 2002 Apr; 440(2-3):173-87. PubMed ID: 12007534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
    Levens NR; Della-Zuana O
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1198-204. PubMed ID: 14649211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics.
    Gehlert DR
    Life Sci; 1994; 55(8):551-62. PubMed ID: 7913982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Y5 neuropeptide Y receptor in feeding and obesity.
    Marsh DJ; Hollopeter G; Kafer KE; Palmiter RD
    Nat Med; 1998 Jun; 4(6):718-21. PubMed ID: 9623983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide y receptor selective ligands in the treatment of obesity.
    Kamiji MM; Inui A
    Endocr Rev; 2007 Oct; 28(6):664-84. PubMed ID: 17785427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice.
    Fukasaka Y; Nambu H; Tanioka H; Obata A; Tonomura M; Okuno T; Yukioka H
    Neuropeptides; 2018 Aug; 70():55-63. PubMed ID: 29801968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y and sleep.
    Dyzma M; Boudjeltia KZ; Faraut B; Kerkhofs M
    Sleep Med Rev; 2010 Jun; 14(3):161-5. PubMed ID: 20122859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food fight: the NPY-serotonin link between aggression and feeding behavior.
    Emeson RB; Morabito MV
    Sci STKE; 2005 Mar; 2005(277):pe12. PubMed ID: 15798100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
    Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
    Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.